Oscar Health (OSCR) Non Operating Interest Expenses (2020 - 2026)

Oscar Health (OSCR) has reported Non Operating Interest Expenses for 7 consecutive years, with $4.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non Operating Interest Expenses fell 19.46% year-over-year to $4.7 million; the trailing twelve-month figure through Jun 2026 stood at $15.9 million (down 33.06% YoY), and the FY2025 full-year result was $17.6 million, down 25.84% from the prior year.
• Non Operating Interest Expenses eased to $4.7 million in Q2 2026 per OSCR's latest filing, from $5.4 million in the prior quarter.
• Across five years, Non Operating Interest Expenses topped out at $6.9 million in Q3 2025 and bottomed at -$1.1 million in Q4 2025.
• Historically, Non Operating Interest Expenses has averaged $5.5 million across 5 years, with a median of $6.0 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Non Operating Interest Expenses jumped 2593.42% in 2022, then slumped 118.2% in 2025.
• Over 5 years, Non Operating Interest Expenses stood at $6.1 million in 2022, then gained by 1.34% to $6.2 million in 2023, then decreased by 3.07% to $6.0 million in 2024, then slumped by 118.2% to -$1.1 million in 2025, then soared by 529.26% to $4.7 million in 2026.
• According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $4.7 million, $5.4 million, and -$1.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.